Acute hemodynamic effects of conivaptan, a dual V1A and V2 vasopressin receptor antagonist, in patients with advanced heart failure

Circulation

Volumn 104, Issue 20, 2001, Pages 2417-2423

  Udelson, James E ^a   Smith, William B ^b   Hendrix, Grady H ^c   Painchaud, Christopher A ^d   Ghazzi, Maha ^d   Thomas, Ignatius ^e   Ghali, Jalal K ^f   Selaru, Paulina ^d   Chanoine, Francoise ^d   Pressler, Milton L ^d   Konstam, Marvin A ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b Louisiana Cardiovascular Research Center   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d PFIZER INC   (United States)

^e Slidell Memorial Hospital   (United States)

^f Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

Heart failure; Hemodynamics; Hormones

Indexed keywords

CONIVAPTAN; PLACEBO; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V2 RECEPTOR;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG INDUCED DISEASE; FEMALE; HEADACHE; HEART FAILURE; HEMODYNAMIC PARAMETERS; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0035856509     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc4501.099313     Document Type: Article

References (23)

1. Vasopressin a therapeutic target in congestive heart failure?
2. 2-vasopressinergic receptors
3. Osmotic and nonosmotic control of vasopressin release
4. Vasopressin increases cytosolic free calcium in neonatal rat cardiocyte: Evidence for VI receptor subtype
5. Effects of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced protein synthesis in neonatal rat cardiomyocyte
6. Hypertrophic growth of cultured neonatal rat heart cells mediated by vasopressin V1a receptor
7. Arginine vasopressin increases the rate of protein synthesis in isolated perfused adult rat heart via the V1 receptor
8. Antidiuretic hormone in congestive heart failure
9. Plasma ADH level in patients with chronic congestive heart failure
10. Increased plasma arginine vasopressin levels in patients with congestive heart failure
11. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: A substudy of the studies of left ventricular dysfunction
12. Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: Comparison with the renin-angiotensin system and the sympathetic nervous system
13. Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: Effect of captopril
14. Differential long-term intrarenal and neurohormonal effects of captopril and prazosin in patients with chronic congestive heart failure: Importance of initial plasma renin activity
15. Plasma vasopressin response to osmotic and hemodynamic stimuli in heart failure
16. Acute hemodynamic effect of vascular antagonist of vasopressin in patients with congestive heart failure
17. Role of antidiuretic hormone in impaired water excretion of patients with congestive heart failure
18. Effects of vasopressin antagonist with combined antipressor and antidiuretic activities in rats with left ventricular dysfunction
19. Pharmacological characterization of YM087, a potent nonpeptide human vasopressin V1A and V2 receptor antagonist
20. 2 receptor antagonist, in dogs with pacing-induced congestive heart failure
21. The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure
22. Medical therapy can improve the biological properties of the chronically failing heart: A new era in the treatment of heart failure
23. Secretory mechanism of immunoreactive endothelin in cultured bovine endothelial cells